A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes

References

• Bray F, Ferlay J, Soerjomataram I, et al.. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo P, He Y, et al. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9:513.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Dou C, et al. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics. 2018;8:4649–4663.
   PubMed Web of Science ®Google Scholar
• Han TS, Ban HS, Hur K, et al.. The Epigenetic Regulation of HCC Metastasis. Int J Mol Sci. 2018;19:3978.
   Web of Science ®Google Scholar
• Fang JH, Zhou HC, Zhang C, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62:452–465.
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. Emerging role of epithelial-mesenchymal transition in hepatic cancer. J Exp Clin Cancer Res. 2016;35:141.
   PubMed Web of Science ®Google Scholar
• Guo D, Li Y, Chen Y, et al. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway. Cell Prolif. 2019;52:e12628.
   PubMed Web of Science ®Google Scholar
• Peng R, Zhang PF, Yang X, et al. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:113.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, et al.. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798–808.
   PubMed Web of Science ®Google Scholar
• Zhao YR, Wang JL, Xu C, et al.. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Clin sci. 2019;133:1645–1662.
   PubMed Web of Science ®Google Scholar
• Shi Y, Qin N, Zhou Q, et al. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J Transl Med. 2017;15:176.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhu H, Liu Q, et al. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:273.
   PubMed Web of Science ®Google Scholar
• Kisoda S, Shao W, Fujiwara N, et al.. Prognostic value of partial EMT-related genes in head and neck squamous cell carcinoma by a bioinformatic analysis. Oral Dis. 2020;26(6):1149–1156. DOI:10.1111/odi.13351.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhou S, Liu B. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients. Biomed Res Int. 2020;2020:7082408.
   PubMed Web of Science ®Google Scholar
• Hua S, Lei L, Deng L, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37:1624–1636.
   PubMed Web of Science ®Google Scholar
• Tong H, Liu X, Li T, et al. NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition. Onco Targets Ther. 2020;13:3931–3942.
   PubMed Web of Science ®Google Scholar
• Wang H, Xu H, Ma F, et al. Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression. Cell Death Dis. 2020;11:225.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Lee JH, Jung S, Park WS, et al. Prognostic nomogram of hypoxia-related genes predicting overall survival of colorectal cancer-Analysis of TCGA database. Sci Rep. 2019;9:1803.
   PubMed Web of Science ®Google Scholar
• Wang X, Yao S, Xiao Z, et al. Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes. J Transl Med. 2020;18:149.
   PubMed Web of Science ®Google Scholar
• Kong F, Zhou K, Zhu T, et al. Interleukin-34 mediated by hepatitis B virus X protein via CCAAT/enhancer-binding protein α contributes to the proliferation and migration of hepatoma cells. Cell Prolif. 2019;52:e12703.
   PubMed Web of Science ®Google Scholar
• Wang L, Sun L, Wang Y, et al. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. Int J Biol Sci. 2019;15:1514–1522.
   PubMed Web of Science ®Google Scholar
• Zhang XP, Jiang YB, Zhong CQ, et al. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway. Cell Physiol Biochem. 2018;47:1643–1654.
   PubMedGoogle Scholar
• Wang J, Hao F, Fei X, et al.. SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c. Am J Transl Res. 2019;11:6924–6937.
   PubMed Web of Science ®Google Scholar
• Shang L, Ye X, Zhu G, et al. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma. Oncotarget. 2017;8:76816–76831.
   PubMedGoogle Scholar
• Liao M, Tong P, Zhao J, et al. Prognostic value of matrix metalloproteinase-1/proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma. Pathol Oncol Res. 2012;18:397–403.
   PubMed Web of Science ®Google Scholar
• Lin Z, He R, Luo H, et al. Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability. J Exp Clin Cancer Res. 2018;37:17.
   PubMed Web of Science ®Google Scholar
• Scheau C, Badarau IA, Costache R, et al. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. Anal Cell Pathol (Amst). 2019;2019:9423907.
   PubMedGoogle Scholar
• Altadill A, Rodríguez M, González LO, et al. Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma. Dig Liver Dis. 2009;41:740–748.
   PubMedGoogle Scholar
• Tu Y, Chen C, Fan G. Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer. BMC cancer. 2019;19:1230.
   PubMed Web of Science ®Google Scholar
• Ouyang G, Yi B, Pan G, et al.. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma. Cancer Cell Int. 2020;20:207.
   PubMed Web of Science ®Google Scholar
• Chen PF, Li QH, Zeng LR, et al. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma. J Cell Biochem. 2019;120:9117–9124.
   PubMed Web of Science ®Google Scholar
• Long J, Zhang L, Wan X, et al. A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma. J Cell Mol Med. 2018;22:5928–5938.
   PubMed Web of Science ®Google Scholar
• Chen Q, Han B, Meng X, et al. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma. Int J Cancer. 2019;145:517–530.
   PubMed Web of Science ®Google Scholar
• Ruvolo PP. Galectins as regulators of cell survival in the leukemia niche. Adv Biol Regul. 2019;71:41–54.
   PubMedGoogle Scholar
• Li JM, Tseng CW, Lin CC, et al. Upregulation of LGALS1 is associated with oral cancer metastasis. Ther Adv Med Oncol. 2018;10:1758835918794622.
   Web of Science ®Google Scholar